Executive Drug Development Consultant, Quotient Sciences

John has almost 20 years industry experience in roles in pharmaceutical sciences with Rhone Poulenc Rorer, Covance and Quotient Sciences, which he joined in 2001. He has been central to Quotient’s integrated approach to drug development and manufacturing which cuts through silos to help biotech/pharma customers shorten timelines in getting new drugs to patients. John has a significant body of experience in dosage form development, clinical manufacturing and product supply strategies.